https://www.selleckchem.com/products/b02.html
This study reports the long-term outcomes using glutaraldehyde-treated cryopreserved homograft pericardium (CPH) in neonates, infants, children, and young adults undergoing congenital cardiac surgery. A retrospective review was performed of all patients at our institution who had undergone surgical implantation with the CPH between 2006 and 2016. We identified 134 consecutive patients implanted with 276 patches. The baseline demographics, primary cardiac diagnosis, surgical characteristics, operative reports, and postoperative catherization
Curtir
Comentario
Compartilhar
